By Analou De Vera The Food and Drug Administration (FDA) has warned the public of the significant risks associated with injecting glutathione to one's body in order to whiten the skin. The FDA noted that it has not approved any injectable products for skin lightening, and that glutathione was only approved by the agency as an "adjunct treatment in cisplatin chemotherapy." "To date there are no published clinical trials that have evaluated the use of injectable glutathione for skin lightening. There are no published guidelines for appropriate dosing regimens and duration of treatment," it stated in its advisory no. 2019-182. "Side effects on the use of injectable glutathione for skin lightening include toxic effects on the liver, kidneys, and nervous system. Also of concern is the possibility of Stevens Johnson Syndrome," it noted. According to the World Health Organization (WHO), Stevens Johnson Syndrome is a "severe blistering rash affecting both skin and mucous membranes." With glutathione affecting the production of melanin, the FDA also said that there were "theoretical concerns" on the possible risk of skin cancer. The public was also warned against injectable Vitamin C which is sometimes being paired with injectable glutathione. "Vitamin C injection may form kidney stones if the urine is acidic. Large doses of Vitamin C have resulted in hemodialysis in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency," the FDA said. The FDA said that it was best to consult only a "board-certified dermatologist" in treating their skin condition. "Avoid buying injectable products online and from being lured to a promising effect of medicines as beauty products," it added.